Gene: LGI3
Official Full Name: leucine rich repeat LGI family member 3provided by HGNC
Gene Summary: Predicted to be involved in regulation of exocytosis. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36105 | LGI3 Knockout cell line (HCT 116) | Human | LGI3 | 1:2~1:4 | Negative | Online Inquiry |
KO36106 | LGI3 Knockout cell line (A549) | Human | LGI3 | 1:3~1:4 | Negative | Online Inquiry |
LGI3 Gene Knockout Cell Lines represent a pioneering biological tool designed to facilitate specific investigations into the role of the LGI3 gene in various cellular processes and diseases. These cell lines are genetically modified to disrupt the expression of LGI3, a gene known to be involved in neuronal development and implicated in the pathology of several neurological disorders. By creating these knockout models, researchers can explore the gene’s function in a controlled environment, providing invaluable insights into its biological contributions.
The core mechanism of the LGI3 Gene Knockout Cell Lines involves CRISPR-Cas9 technology or similar gene-editing tools that ensure precise alterations of the genomic sequence, leading to the complete ablation of LGI3 expression. This allows scientists to study the resulting phenotypic changes and signaling pathways altered by the absence of LGI3, contributing to a deeper understanding of its role in synaptic transmission, neuroinflammation, and other critical biological phenomena.
The scientific significance of these knockout cell lines extends to multiple applications, particularly in research focused on neurobiology, drug discovery, and the development of potential therapeutic strategies for conditions associated with LGI3 dysregulation. Utilizing these tools can enhance the understanding of disease mechanisms at a molecular level, supporting the transition from basic science to clinical applications.
Compared to alternative models, such as wild-type or overexpressing cell lines, LGI3 Gene Knockout Cell Lines provide a unique advantage by enabling researchers to pinpoint the specific consequences of LGI3 loss-of-function. This specificity leads to more accurate interpretations of experimental results and fosters the development of targeted interventions.
For researchers and clinicians, the LGI3 Gene Knockout Cell Lines represent a significant investment in advancing scientific understanding and therapeutic innovations, making them an essential addition to any laboratory focused on neurology and molecular biology.
With a commitment to excellence in innovative biological products, our company leverages cutting-edge technology and extensive expertise to deliver high-quality genetic models that further research objectives and propel discovery forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.